Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Top Cited Papers
Open Access
- 13 December 2012
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 62 (1) , 194-204
Abstract
Despite the recent attention focused on the roles of the nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome in the pathogenesis of type 2 diabetes, little is known about the ex vivo profile of inflammasome activation in type 2 diabetic patients. In this study, we investigated patterns of NLRP3 inflammasome activation in monocyte-derived macrophages (MDMs) from drug-naïve patients with newly diagnosed type 2 diabetes. Type 2 diabetic subjects had significantly increased mRNA and protein expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), and proinflammatory cytokines in MDMs cultured with autologous sera compared with healthy controls. Upregulated interleukin (IL)-1β maturation, IL-18 secretion, and caspase-1 cleavage were observed in MDMs from type 2 diabetic patients after stimulation with various danger molecules (ATP, high-mobility group protein B1, free fatty acids, islet amyloid polypeptide, and monosodium uric acid crystals). Mitochondrial reactive oxygen species and NLRP3 were required for IL-1β synthesis in MDMs. Finally, 2 months of therapy with the antidiabetic drug metformin significantly inhibited the maturation of IL-1β in MDMs from patients with type 2 diabetes through AMP-activated protein kinase (AMPK) activation. Taken together, these data suggest that NLRP3 inflammasome activation is elevated in myeloid cells from type 2 diabetic patients and that antidiabetic treatment with metformin contributes to modulation of inflammasome activation in type 2 diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin‐1–Syk and p62/SQSTM1Immunology & Cell Biology, 2011
- NLRP3 inflammasomes link inflammation and metabolic diseaseTrends in Immunology, 2011
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsNature Reviews Drug Discovery, 2011
- Oxidative stress, insulin signaling, and diabetesFree Radical Biology and Medicine, 2011
- Inflammasomes and autoimmunityTrends in Molecular Medicine, 2011
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasomeNature Immunology, 2010
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- Sensing pathogens and danger signals by the inflammasomeCurrent Opinion in Immunology, 2009